DANIEL UDERITZ: Open Payments
NPI 1295963437 · JOHNS ISLAND, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,853 in 243 payments from 23 companies in 2025. Trend: 2023 $3,584 · 2024 $3,988 · 2025 $4,853
Food & beverage: $4,853
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 27 | $601 |
| Axsome Therapeutics, Inc. | 22 | $534 |
| Teva Pharmaceuticals USA, Inc. | 27 | $524 |
| E.R. Squibb & Sons, L.L.C. | 17 | $434 |
| ABBVIE INC. | 22 | $336 |
| Lundbeck LLC | 17 | $303 |
| Otsuka America Pharmaceutical, Inc. | 18 | $286 |
| Neurocrine BioSciences, Inc. | 12 | $274 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $251 |
| Supernus Pharmaceuticals, Inc. | 9 | $192 |
Products named: HETLIOZ, Auvelity, REXULTI, COBENFY, VRAYLAR, INGREZZA, AUSTEDO XR, CAPLYTA.
Industry payments across SC — which companies pay providers there.
